Correlation Between Reviva Pharmaceuticals and Tempest Therapeutics

Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Tempest Therapeutics, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Tempest Therapeutics.

Diversification Opportunities for Reviva Pharmaceuticals and Tempest Therapeutics

0.71

Correlation Coefficient

Reviva Pharmaceuticals  Tempest Therapeutics

Poor diversification

The 3 months correlation between Reviva and Tempest is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Tempest Therapeutics go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Tempest Therapeutics

Given the investment horizon of 90 days Reviva Pharmaceuticals Holdings is expected to under-perform the Tempest Therapeutics. In addition to that, Reviva Pharmaceuticals is 1.71 times more volatile than Tempest Therapeutics. It trades about -0.13 of its total potential returns per unit of risk. Tempest Therapeutics is currently generating about 0.02 per unit of volatility. If you would invest  84.00  in Tempest Therapeutics on December 28, 2024 and sell it today you would earn a total of  0.00  from holding Tempest Therapeutics or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Reviva Pharmaceuticals Holding  vs.  Tempest Therapeutics

Reviva Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Reviva Pharmaceuticals Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Tempest Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Tempest Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Tempest Therapeutics is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Reviva Pharmaceuticals and Tempest Therapeutics

The main advantage of trading using opposite Reviva Pharmaceuticals and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.

The idea behind Reviva Pharmaceuticals Holdings and Tempest Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.